Author

Andrew G Sikora

University of Texas MD Anderson Cancer Center - Cited by 9,136 - immunology - immunotherapy - head and neck cancer - melanoma

Biography

Dr. Andrew Sikora is a Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He also serves as Director of Research for Head and Neck Surgery. Dr. Sikora’s clinical expertise is in oropharyngeal (throat) cancer and human papillomavirus (HPV)-related head and neck cancer. His research is focused on tumor immunology, and cancer immunotherapy. Dr. Sikora serves as a member of the National Institute of Health (NIH) National Cancer Institute’s Head and Neck Cancer Core Committee, and Immuno-Oncology Translational Network (IOTN) Steering Committee.
Title
Cited by
Year
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ...Cancer cell 39 (3), 361-379. e16, 2021202
160
2021
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
S Demaria, C Guha, J Schoenfeld, Z Morris, A Monjazeb, A Sikora, ...Journal for immunotherapy of cancer 9 (4), 2021202
101
2021
Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis
B Uzunparmak, M Gao, A Lindemann, K Erikson, L Wang, E Lin, SJ Frank, ...JCI insight 5 (23), 2020202
29
2020
24
2021
Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
R Veeramachaneni, W Yu, JM Newton, JO Kemnade, HD Skinner, ...Journal for immunotherapy of cancer 9 (7), 2021202
22
2021
The role of human papillomavirus in the pathogenesis of sinonasal inverted papilloma: A narrative review
R Gupta, PL Rady, AG Sikora, SK TyringReviews in Medical Virology 31 (3), e2178, 2021202
16
2021
Biomaterial-facilitated immunotherapy for established oral cancers
DG Leach, N Dharmaraj, TL Lopez-Silva, JR Venzor, BH Pogostin, ...ACS biomaterials science & engineering 7 (2), 415-421, 2021202
16
2021
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma
CF Koyuncu, C Lu, K Bera, Z Zhang, J Xu, P Toro, G Corredor, D Chute, ...The Journal of Clinical Investigation 1 (8), 2021202
13
2021
Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response
KM Ahmed, R Veeramachaneni, D Deng, N Putluri, V Putluri, ...Journal for immunotherapy of cancer 10 (8), 2022202
12
2022
Impact of adjuvant medical therapies on surgical outcomes in idiopathic subglottic stenosis
MR Hoffman, A Patro, LC Huang, SC Chen, LD Berry, A Gelbard, ...The Laryngoscope 131 (12), E2880-E2886, 2021202
11
2021
Local anti–PD-1 delivery prevents progression of premalignant lesions in a 4NQO-oral carcinogenesis mouse model
Y Shi, T Xie, DG Leach, B Wang, S Young, AA Osman, AG Sikora, X Ren, ...Cancer Prevention Research 14 (8), 767-778, 2021202
11
2021
Genetic changes driving immunosuppressive microenvironments in oral premalignancy
R Rangel, CR Pickering, AG Sikora, MT SpiottoFrontiers in immunology 13, 84023, 2022202
9
2022
Esomeprazole enhances the effect of ionizing radiation to improve tumor control
KA Hebert, S Jaramillo, W Yu, M Wang, R Veeramachaneni, ...Oncotarget 12 (14), 1339, 2021202
8
2021
Biomarkers for malignant potential in vocal fold leukoplakia: a state of the art review
P Wan, J Ongkasuwan, J Martinez, V Sandulache, D Deng, J Jiang, ...Otolaryngology–Head and Neck Surgery 164 (4), 751-75, 2021202
8
2021
The proximal airway is a reservoir for adaptive immunologic memory in idiopathic subglottic stenosis
A Gelbard, C Wanjalla, CT Wootten, WP Drake, AS Lowery, DA Wheeler, ...The Laryngoscope 131 (3), 610-61, 2021202
7
2021
Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy
A Vyas, R Gomez-Casal, S Cruz-Rangel, H Villanueva, AG Sikora, ...Proceedings of the National Academy of Sciences 119 (12), e210060119, 2022202
7
2022
5
2022
Prospective clinical investigation of the efficacy of combination radiation therapy with immune checkpoint inhibition
EH Akama-Garren, ZS Morris, AG Sikora, R Weichselbaum, ...International Journal of Radiation Oncology* Biology* Physics 111 (), 116-117, 2021202
5
2021
Association of social determinants of health with time to diagnosis and treatment outcomes in idiopathic subglottic stenosis
J Lee, LC Huang, LD Berry, C Anderson, MR Amin, MS Benninger, ...Annals of Otology, Rhinology & Laryngology 130 (10), 1116-1124, 2021202
5
2021
Oral squamous cell carcinoma outcome in adolescent/young adult: Systematic review and m eta‐analysis
E Kaminagakura, RN Tango, D Cruz‐Perez, R Bonan, ...Head & Neck 44 (2), 48-61, 2022202
5
2022